Illumina owned startup, Grail has announced that it is in the process of raising more than $1 billion in venture capital to invest in its cancer detection test and it split from its parent company. If Grail succeeds in raising $1 billion in its second round of financing, this would for the first time put a […]
Illumina has announced the launch of its spin-off Grail, a company dedicated to implement cancer screenings based on blood tests. Grail will use Illumina’s sequencing technology to detect several cancer types by checking the nucleic acids in the blood. The new test would allow early cancer detection in asymptomatic people, dramatically reducing cancer-related death by treating individuals […]
